Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

Cancer Research UK, the UK National Cancer Research Network, the Wessex Cancer Trust, Breast Cancer Now, and the PPP Healthcare Medical Trust Grant.